Literature DB >> 23225511

Gram-negative infection and bronchiectasis in lung transplant recipients with bronchiolitis obliterans syndrome.

Don Hayes1, Aaron Weiland, Stephen Kirkby, Mark Galantowicz, Patrick I McConnell, Joseph D Tobias.   

Abstract

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after lung transplantation manifests as a gradual decline in forced expiratory volume in 1 second. Bronchiectasis is often seen but occurs at variable rates with the underlying pathogenesis being unclear.
OBJECTIVE: We completed a study to determine whether lower airway infection with gram-negative bacilli was associated with the development of bronchiectasis in lung transplant recipients with BOS.
METHODS: A retrospective review of 17 lung transplant recipients (age: 28 ± 7 years, range: 13 to 40 years) in a patient population transplanted for cystic fibrosis (CF) 82% (14/17), bronchiolitis obliterans 12% (2/17), and sarcoidosis 6% (1/17) was completed. Each patient completed pulmonary function testing and underwent annual computed tomographic imaging of the chest for surveillance posttransplant at a single transplant center.
RESULTS: Bronchiectasis was present in 70% (12/17) of patients whereas 94% (16/17) of patients had varying severity of BOS: 1 (n = 7), 2 (n = 3), and 3 (n = 6). All 12 patients with bronchiectasis had an allograft gram-negative rod infection and 92% (11/12) of them had BOS.
CONCLUSIONS: The presence of bronchiectasis in lung transplant recipients with BOS was associated with a gram-negative bacterial airway infection of the allograft in a small cohort of predominately lung transplant recipients with CF. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23225511     DOI: 10.1055/s-0032-1322619

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

Review 1.  How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams
Journal:  Blood       Date:  2016-11-16       Impact factor: 22.113

Review 2.  The lung microbiome after lung transplantation.

Authors:  Julia Becker; Valeriy Poroyko; Sangeeta Bhorade
Journal:  Expert Rev Respir Med       Date:  2014-04       Impact factor: 3.772

Review 3.  The respiratory microbiome after lung transplantation: Reflection or driver of respiratory disease?

Authors:  Caroline C Eskind; Meghan H Shilts; Ciara M Shaver; Suman R Das; Gowri Satyanarayana
Journal:  Am J Transplant       Date:  2021-04-16       Impact factor: 8.086

4.  Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction.

Authors:  L A Borthwick; M I Suwara; S C Carnell; N J Green; R Mahida; D Dixon; C S Gillespie; T N Cartwright; J Horabin; A Walker; E Olin; M Rangar; A Gardner; J Mann; P A Corris; D A Mann; A J Fisher
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

5.  HIV-1 Productively Infects and Integrates in Bronchial Epithelial Cells.

Authors:  Dinesh Devadoss; Shashi P Singh; Arpan Acharya; Kieu Chinh Do; Palsamy Periyasamy; Marko Manevski; Neerad Mishra; Carmen S Tellez; Sundaram Ramakrishnan; Steven A Belinsky; Siddappa N Byrareddy; Shilpa Buch; Hitendra S Chand; Mohan Sopori
Journal:  Front Cell Infect Microbiol       Date:  2021-02-04       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.